Daily Market News Update — 30th-31st July 2026

Midnight News Update: 30-31 Jul 2026

Indian cost arbitrage extends not just to IT and Pharma, but also to defence. Now Indian missile systems are winning global orders, being almost 50% cheaper than their Western peers, for the same level of performance. In the global market, where price matters as much as performance, India’s Akash, Pinaka, Brahmos and Nagastra are positioning India as a serious arms supplier to Asia, Africa, and the Middle East. Across missile and rocket systems, Indian missiles are roughly 20% to 50% cheaper. India also has a cost-edge in surface-to-air missiles.

With India likely to intensify its shift to renewable energy, a massive investment of ₹9 trillion is expected to happen in transmission infrastructure. This is proving to be a boom for several companies in the transformer and transmission equipment space. Demand in the domestic power transformer market is expected to grow from the current ₹35,000 crore to ₹85,000 crore by FY29. Companies likely to benefit most from this grid upgrade are names like CG Power & Industrial, Transformers & Rectifiers, Atlanta Electricals etc. Order books are already at a record.

For Q1FY27, M&M had reported 33.6% higher net profits at ͅ₹5,455 crore. Revenues for the quarter were up 26.6% at ₹57,534 crore. Both, the revenues and net profits were up on a sequential basis too. Within the group businesses, the auto and farm businesses strengthened its leadership position in their specific segments. M&M gained market share in SUVs and also in LCVs. Tractors business touched a market share of 44.9% in the quarter. The auto and tractors business of M&M has benefited substantially from the GST cuts implemented by government last year.

The AI bubble may be gradually unravelling globally, but Indian IT is surely celebrating. IT stocks have rallied in the month of July 2026, and it may turn out to be the best month in the last 6 years. The AI investors are increasingly asking questions on ROI and that has led to the KOSPI falling by nearly 44% in the last 2 months. For the month of July alone, the Indian IT index has rallied nearly 16% as investors gravitated towards the safety of good old IT models. Interestingly, the NASDAQ is now about 11% below its June peak levels. Buying was seen in large-cap and mid-cap IT.

Coal India is likely to fire up its capital expenditure with an outlay of nearly ₹68,000 crore over the next 4 years. The big question is what is Coal India going to do with this sort of massive capex outlay? The primary focus of Coal India will be on expansion of capacity to bring more coal to the market to meet the increasing demands of the power sector, as well as strengthening its mining infrastructure. A good portion of the capital outlay is also directed towards land acquisition and for resettlement costs. It will also invest heavily in coal evacuation systems.

ChrysCapital has just closed its first majority pharma investment, buying 70.68% stake in Novartis India from the Swiss parent. ChrysCapital plans to build a leading branded generics platform to focus on Indian markets. Novartis India has presence across pain management, calcium supplements, gynaecology, and neurosciences; with marquee brands like Voveran, Calcium Sandoz, and Tegrital. Over the years, Novartis India has built scientific rigor and physician trust, which has to be transposed to the new model. It is another case of PE funds investing in healthcare.

Bajaj Finance has reported a 27% growth in net profits in Q1FY27 to ₹5,986 crore, continuing its steady growth trajectory. AUM grew 23% yoy to ₹4,00,389 crore. For the quarter, net interest income (NII) was up 24% at ₹11,495 crore, while loan loss provisions were lower by 13% in Q1. Gross NPAs tapered to 1.2%, while the net NPAs tapered to 0.49% as of June 2026. The provisioning coverage ratio (PCR) stood at 60% for Stage-3 assets. Bajaj Finance benefited in Q1FY27 from robust retail credit demand and more stringent credit underwriting standards.

Vedanta group will demerge its real estate franchise into a separate company, Vedanta Property Platforms Ltd (VPPL). As of now, the realty business is quite small, but is part of the long-term value realignment strategy. Earlier, Vedanta had split its business into 5 listed business verticals along key product lines. For the shareholders of Vedanta, the ratio eligibility will be 1 share of VPPL for every 20 shares of Vedanta Ltd held. The demerged company will have a portfolio comprising of 2,200 acres of industrial land and 55,000 SFT for commercial and residential properties.